# Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity

> **NCT07072000** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Hai-Qiang Mai,MD,PhD** · enrollment: 550 (estimated)

## Conditions studied

- Nasopharyngeal Cancinoma (NPC)

## Interventions

- **RADIATION:** standard CTV delineation
- **RADIATION:** reduced CTV delineation

## Key facts

- **NCT ID:** NCT07072000
- **Lead sponsor:** Hai-Qiang Mai,MD,PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2030-07-31
- **Final completion:** 2032-07-31
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2025-07-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07072000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07072000, "Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07072000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*